Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.23.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of March 31, 2023:

 

    Awards     Awards         Awards  
   

Reserved for

Issuance

    Issued & Outstanding    

Awards

Exercised

   

Available for

Grant

 
2019 Plan(1)     871,429       627,219       7,183       237,027  
Awards granted outside of the 2019 Plan(2)     -       37,037       11,364       -  

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.
Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the period ended March 31, 2023:

 

                Weighted  
          Weighted     Average  
          Average     Contractual  
    Number of     Exercise     Term in  
    Options     Price     Years  
Outstanding at January 1, 2023     524,937     $ 2.351416       8.38  
Granted     17,532       2.00       10.0  
Exercised                  
Forfeited                  
Cancelled                  
Expired                  
Outstanding at March 31, 2023     542,469     $ 2.340058       8.20  
Exercisable at March 31, 2023     351,398     $ 1.777947       7.42  
Schedule of Assumptions used in Share-based Compensation

 

Volatility     257.64 %
Risk-free interest rate     4.21 %
Dividend yield     0.0 %
Expected term     5.50 years  
Schedule of Restricted Stock Units Granted

 

          Weighted  
          Average  
    Number of     Grant Date  
    Units     Fair Value  
Outstanding at January 1, 2023     90,432     $ 1.43  
Granted     37,037       1.35  
Exercised and converted to common shares     (5,682 )     4.40  
Forfeited            
Outstanding at March 31, 2023     121,787     $ 1.68  
Exercisable at March 31, 2023     30,466     $ 1.68  
Summary of Common Stock Warrants

The following table shows a summary of common stock warrants through March 31, 2023:

 

      Weighted     Weighted  
      Average     Average  
  Number of     Exercise     Contractual  
  Warrants     Price     Term in Years  
Outstanding at January 1, 2023     3,637,190     $ 5.16281       3.65  
Granted                  
Exercised     (30,430)       0.69        
Forfeited                  
Cancelled     (49,570)       1.18        
Expired                  
Outstanding at March 31, 2023     3,557,190     $ 5.256569       3.47  
Exercisable at March 31, 2023     3,557,190     $ 5.256569       3.47